| Literature DB >> 25262435 |
Rianne Hj Golsteijn, Denise A Peels, Silvia Maa Evers, Catherine Bolman, Aart N Mudde, Hein de Vries, Lilian Lechner.
Abstract
BACKGROUND: The adverse health effects of insufficient physical activity (PA) result in high costs to society. The economic burden of insufficient PA, which increases in our aging population, stresses the urgency for cost-effective interventions to promote PA among older adults. The current study provides insight in the cost-effectiveness and cost-utility of different versions of a tailored PA intervention (Active Plus) among adults aged over fifty.Entities:
Mesh:
Year: 2014 PMID: 25262435 PMCID: PMC4189727 DOI: 10.1186/s12966-014-0122-z
Source DB: PubMed Journal: Int J Behav Nutr Phys Act ISSN: 1479-5868 Impact factor: 6.457
Figure 1Participant flow through the Active Plus intervention Note: Percentages of the 6 and 12 months assessment are reported in contrast to the number of baseline participants.
Baseline characteristics, mean and standard deviation (SD)
|
|
|
|
|
|
|
|
| |
|---|---|---|---|---|---|---|---|---|
| Mean age (years)(SD) | 64.2 (9.5) | 63.1 (8.7) | 64.0 (9.4) | 61.8 (7.1) | 60.8 (7.5) | 12.05 | 0.00a | |
| Gender (% men) | 49.9 | 45.9 | 45.3 | 52.3 | 51.3 | 10.63 | 0.22 | |
| Education (% low) | 50.3 | 43.5 | 47.3 | 46.1 | 47.8 | 4.04 | 0.40 | |
| Paid job (%) | 42.8 | 40.1 | 43.9 | 36.8 | 40.2 | 5.14 | 0.27 | |
| Physical activity | ||||||||
| MET-hours PA/week (SD) | 45.4 (40.0) | 41.6 (37.7) | 41.5 (32.1) | 42.9 (38.9) | 43.0 (40.7) | 0.71 | 0.58 | |
| Minutes MVPA/week (SD) | 806.7 (786.8) | 741.3 (739.1) | 711.7 (646.7) | 684.8 (719.9) | 733.4 (721.0) | 1.63 | 0.16 | |
| Days with sufficient PA (SD) | 3.8 (2.1) | 4.0 (2.0) | 3.9 (2.0) | 4.3 (2.1) | 4.0 (1.9) | 4.95 | 0.00b | |
| Mean utility (SD) | 0.873 (0.180) | 0.870 (0.166) | 0.891 (0.150) | 0.880 (0.163) | 0.890 (0.158) | 1.17 | 0.32 | |
| Mean health care costs (SD) | 1012 (3751) | 713 (1568) | 625 (1532) | 733 (1372) | 686 (1907) | 1.94 | 0.10c | |
| Mean participant and family costs (SD) | 272 (624) | 352 (922) | 274 (602) | 405 (1060) | 331 (1001) | 1.78 | 0.13d | |
| Mean productivity losses (SD) | 220 (2547) | 196 (1069) | 199 (1009) | 465 (2758) | 309 (1694) | 1.63 | 0.17 | |
| Mean societal costs (SD) | 1683 (4993) | 1254 (2315) | 1083 (2001) | 1583 (3406) | 1290 (2876) | 2.41 | 0.05c |
NB: all costs are expressed in Euro’s.
aPost-hoc analysis revealed significant differences: C > WB; C > WE; PB > WE; PE > WB; PE > WE.
bPost-hoc analysis revealed significant differences: C < WB; PE < WB.
cBootstrap analysis revealed significant differences: C > PE.
dBootstrap analysis revealed significant differences: C < WB; PE < WB.
Costs and effectiveness outcomes of the Active Plus intervention conditions at 12 months follow-up
|
|
| |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Intervention costs | - | 0 | 25.77 | 31.21 | 15.53 | 18.83 | - | - | - | - | - | - | - | - |
| Health care costs | 1682 (200) | 1423 (131) | 1320 (162) | 1437 (129) | 1406 (189) | −739 to 181 | −873 to 122 | −733 to 201 | −813 to 267 | −508 to 315 | −452 to 434 | −372 to 349 | −593 to 397 | |
| General practitioner | 29.02b | 126 (11) | 122 (7) | 117 (9) | 125 (9) | 143 (11) | −29 to 21 | −36 to 18 | −30 to 25 | −13 to 48 | −25 to 17 | −8 to 47 | −25 to 19 | −55 to 1 |
| Life style coach | 27.98b | 16 (4) | 16 (4) | 18 (5) | 20 (5) | 33 (10) | −12 to 12 | −12 to 15 | −8 to 18 | −2 to 39 | −11 to 15 | −8 to 35 | −17 to 8 | −38 to 5 |
| Paramedical care | 35.96b | 298 (36) | 285 (34) | 191 (23) | 281 (32) | 233 (32) | −111 to 85 | −195 to −27* | −112 to 80 | −158 to 28 | −175 to −14* | −137 to 40 | −87 to 95 | −121 to 36 |
| Mental health care | 82.92b | 48 (19) | 58 (31) | 20 (7) | 67 (20) | 38 (11) | −53 to 92 | −72 to 8 | −36 to 72 | −55 to 30 | −112 to 7 | −76 to 14 | −73 to 71 | −43 to 6 |
| Company doctor | 72.48c | 15 (4) | 14 (5) | 11 (4) | 23 (6) | 7 (3) | −13 to 12 | −14 to 7 | −6 to 23 | −18 to 1 | −15 to 9 | −30 to −3* | −25 to 7 | −4 to 14 |
| Social worker | 67.37b | 4 (2) | 10 (8) | 12 (9) | 28 (14) | 5 (2) | −5 to 25 | −5 to 29 | 1 to 57* | −5 to 8 | −20 to 25 | −55 to 1 | −52 to 12 | −7 to 29 |
| Practice nurse | 15.81b | 5 (1) | 4 (2) | 10 (4) | 12 (3) | 10 (2) | −4 to 3 | −2 to 15 | 2 to 15* | 0 to 10 | −2 to 16 | −12 to 5 | −17 to −2* | −8 to 11 |
| Medical specialist | 74.62b | 135 (11) | 120 (11) | 130 (11) | 138 (11) | 150 (14) | −44 to 15 | −35 to 27 | −27 to 34 | −18 to 50 | −21 to 41 | −22 to 47 | −48 to 13 | −57 to 15 |
| Hospital admission | 473.65b | 418 (75) | 366 (98) | 374 (114) | 291 (56) | 427 (131) | −285 to 201 | −288 to 243 | −317 to 52 | −258 to 334 | −281 to 306 | −105 to 444 | −128 to 307 | −401 to 288 |
| Medication | Varyingd | 346 (56) | 271 (29) | 329 (84) | 340 (70) | 308 (98) | −208 to 40 | −195 to 201 | −177 to 184 | −229 to 215 | −84 to 258 | −256 to 229 | −234 to 60 | −249 to 266 |
| Paid homecare | 35.84b | 270 (119) | 172 (28) | 116 (28) | 99 (31) | 88 (20) | −379 to 93 | −428 to 34 | −451 to 19 | −461 to 2 | −134 to 21 | −87 to 59 | −8 to 156 | −39 to 97 |
| Other health care | Varyinge | 24 (14) | 5 (2) | 5 (2) | 24 (13) | 6 (2) | −51 to 2 | −50 to 2 | −39 to 38 | −50 to 4 | −5 to 5 | −49 to 2 | −50 to 1 | −6 to 4 |
| Participant & family costs | 567 (47) | 604 (57) | 631 (70) | 648 (68) | 585 (59) | −106 to 187 | −99 to 231 | −76 to 244 | −128 to 169 | −152 to 209 | −243 to 112 | −215 to 120 | −134 to 232 | |
| Physical activity costs | - | 371 (30) | 387 (39) | 363 (33) | 349 (36) | 285 (30) | −81 to 111 | −94 to 81 | −115 to 75 | −169 to −1* | −126 to 77 | −158 to 27 | −69 to 140 | −8 to 167 |
| Travel costs | Varyingb | 75 (6) | 71 (6) | 61 (5) | 79 (6) | 74 (6) | −19 to 12 | −28 to 1 | −12 to 21 | −18 to 16 | −25 to 5 | −21 to 13 | −24 to 9 | −29 to 3 |
| Unpaid homecare | 12.80b | 126 (32) | 155 (40) | 218 (63) | 230 (57) | 235 (51) | −69 to 135 | −41 to 242 | −16 to 236 | −9 to 229 | −80 to 219 | −154 to 146 | −218 to 54 | −172 to 147 |
| Productivity losses | - | 485 (117) | 369 (118) | 296 (102) | 986 (246) | 526 (159) | −443 to 214 | −498 to 113 | 12 to 1068* | −334 to 448 | −383 to 230 | −1047 to 99 | −1179 to −124* | −632 to 114 |
| Societal costs | - | 2737 (258) | 2448 (204) | 2306 (223) | 3052 (301) | 2516 (273) | −936 to 345 | −1098 to 235 | −451 to 1090 | −966 to 521 | −737 to 454 | −1338 to 256 | −1339 to 100 | −912 to 444 |
|
| ||||||||||||||
|
|
|
|
|
|
|
|
| |||||||
| Δ MET hours PA/week | −2.2 (29.1) | 3.0 (28.2) | 2.7 (27.9) | 0.7 (27.8) | −0.4 (31.6) | 2.39 | 0.05 | |||||||
| Δ Minutes MVPA/week | −72.1 (500.9) | 3.1 (533.8) | 37.7 (506.1) | −32.8 (445.2) | −39.8 (522.7) | 2.96 | 0.02 | |||||||
| Δ days with sufficient PA | 0.1 (1.7) | 0.4 (1.7) | 0.5 (1.6) | 0.0 (1.4) | 0.2 (1.3) | 5.87 | 0.00 | |||||||
| QALY-EQ-5D-3L | 0.884 (0.164) | 0.876 (0.155) | 0.883 (0.160) | 0.883 (0.162) | 0.888 (0.165) | 0.339 | 0.85 | |||||||
C = control group, PB = printed basic intervention, PE = printed environmental intervention, WB = Web-based basic intervention, WE = Web-based environmental intervention.
aUnit cost prices are indexed to 2011 costs, based on consumer price index [44]; bbased on Dutch guidelines [27]; cbased on Collective Agreement for company doctors in the Netherlands (2002); dadapted from www.medicijnkosten.nl based on Defined Daily Dose [43]; eadapted from several resources including Hakkaart – van Roijen et al. [27], detailed specification available upon request; *Significant difference (the 95% CI does not include zero).
Figure 2Cost-effectiveness acceptability curves (CEAC) comparing the intervention as a whole (AP) to the control group (C).
Incremental cost-effectiveness (ICER) and cost-utility (ICUR) ratios of the Active Plus intervention conditions
|
|
| |||||
|---|---|---|---|---|---|---|
|
|
|
|
|
|
| |
|
| ||||||
| Intervention as a whole | −174 | 3.8 | −46e | −153 | −0.002 | 101,169f |
| PB | −288 | 5.3 | −55e | −315 | −0.008 | 38,120f |
| PE | −464 | 5.0 | −94e | −434 | −0.001 | 405,892f |
| WB | 318 | 3.0 | 108h | 364 | −0.001 | 440,164g |
| WE | −255 | 1.8 | −139e | −211 | 0.004 | −47,293e |
|
| ||||||
| PE vs. PB | −176 | −0.3 | 555h | −119 | 0.007 | −16,516e |
| WE vs. WB | −573 | −1.1 | 514h | −575 | 0.005 | −108,851e |
|
| ||||||
| PB vs. WB | −606 | 2.3 | −261e | −679 | −0.007 | 91,336f |
| PE vs. WE | −209 | 3.1 | −67e | −223 | −0.006 | 40,426f |
C = control group, PB = printed basic intervention, PE = printed environmental intervention, WB = Web-based basic intervention, WE = Web-based environmental intervention.
aIn Euros; bdifferences in incremental costs for the ICER and ICUR occur due to differences in the number of participants for which MET-hours/week and QALYs were available; ccalculated according to the formula ICER (or ICUR) = (Costsi-Costsc)/(Effecti-Effectc); dBased on the Dutch algorithm for the EuroQol (EQ-5D-3L) scores; edominant; fdominant based on WTP = €20,000 (i.e. savings larger than WTP); gdominated; hpreferred intervention depends on WTP (unknown for PA).
Figure 3Cost-effectiveness acceptability curves (CEAC) comparing the different intervention conditions.
Primary and sensitivity analyses of the Active Plus intervention conditions at the 12-month follow-up
|
|
|
|
|
|
|
| ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
|
|
| |||
|
| ||||||||||||
| PA (MET-hours/week) | 2760 (5301) | -2.2 | 2472 (4269) | 3.0 | 2295 (4694) | 2.7 | 3078 (6301) | 0.7 | 2504 (5666) | -0.4 | 555 (PE vs PB) | <€1000 PE, >€1000 PBPB: 50%; PE: 43% |
| QALY-EQ-5D-3Lc | 2739 (5293) | 0.884 | 2424 (4212) | 0.876 | 2305 (4642) | 0.883 | 3103 (6378) | 0.883 | 2528 (5730) | 0.888 | 40426 (PE vs WE) | <€40000 PE, >€40000 WE; |
|
| ||||||||||||
|
| ||||||||||||
| PA (MET-hours/week) | 1444 (2988) | 7.4 | 1329 (2880) | 11.5 | 1106 (2456) | 15.6 | 1501 (3207) | 13.9 | 1201 (2663) | 8.1 | PE dominant | PE at any threshold; PE: 74% |
| QALY-EQ-5D-3Lc | 1442 (2985) | 0.442 | 1307 (2860) | 0.438 | 1106 (2426) | 0.441 | 1547 (3305) | 0.442 | 1211 (2683) | 0.444 | 38110 (PE vs WE) | <€45000 PE, >€45000 WE; PE: 56% |
|
| ||||||||||||
| PA (MET-hours/week) | 2382 (3880) | -2.5 | 2592 (4666) | 6.3 | 2316 (4986) | 5.7 | 2824 (5241) | 1.7 | 2217 (3316) | 4.1 | 472 (PE vs PB) | <€50 WE, >€50 < €400 PE, >€400 PB; PB: 44% |
| QALY-EQ-5D-3Lc | 2488 (4212) | 0.902 | 2423 (4452) | 0.878 | 2166 (4668) | 0.898 | 2635 (5031) | 0.893 | 2198 (3774) | 0.892 | PE dominant | PE at any threshold; |
|
| ||||||||||||
| PA (ME- hours/week) | 2862 (3742) | -2.2 | 2664 (3277) | 3.0 | 2614 (3824) | 2.7 | 3038 (4593) | 0.7 | 2794 (4618) | -0.5 | 157 (PE vs PB) | <€175 PE, >€175 PB; PB: 54% |
| QALY-EQ-5D-3Lc | 2851 (3737) | 0.884 | 2633 (3252) | 0.876 | 2622 (3811) | 0.883 | 3045 (4643) | 0.883 | 2795 (4667) | 0.888 | 31308 (PE vs WE) | <€30000 PE, >€30000 WE; PE: 38% |
|
| ||||||||||||
| PA (MET-hours/week) | 1693 (4093) | -2.2 | 1441 (2817) | 3.0 | 1297 (3340) | 2.7 | 1438 (2658) | 0.7 | 1419 (3963) | -0.4 | 452 (PE vs PB) | <€400 PE, >€400 PB; PB: 53% |
| QALY-EQ-5D-3Lc | 1670 (4082) | 0.884 | 1386 (2729) | 0.876 | 1287 (3256) | 0.883 | 1428 (2664) | 0.883 | 1386 (3965) | 0.888 | 17966 (PE vs WE) | <€12500 PE, >€12500 WE; WE: 42% |
|
| ||||||||||||
| Minutes MVPA/week | 2749 (5264) | -72.1 | 2463 (4241) | 3.1 | 2306 (4696) | 37.7 | 3078 (6301) | -32.8 | 2504 (5666) | -39.8 | PE dominant | PE at any threshold; PE: 83% |
| Days with sufficient PA | 2720 (5349) | 0.1 | 2520 (4303) | 0.4 | 2341 (4740) | 0.5 | 3076 (6286) | 0.0 | 2503 (5645) | 0.2 | PE dominant | PE at any threshold; PE: 76% |
| QALY-EQ-5D-3L UK tariff | 2739 (5293) | 0.858 | 2424 (4212) | 0.846 | 2305 (4642) | 0.856 | 3103 (6378) | 0.857 | 2528 (5730) | 0.864 | 25001 (PE vs WE) | <€25000 PE, >€25000 WE; PE: 42% |
PB = printed basic intervention, PE = printed environmental intervention, WB = Web-based basic intervention, WE = Web-based environmental intervention, C = control group.
aIn Euros; bcalculated according to the formula ICER = (Ci-Cc)/ (Ui-Uc); cBased on the Dutch algorithm for the EuroQol (EQ-5D-3L) scores; dCost-effectiveness acceptability frontiers (CEAF); eProbability of highest net monetary benefit (NMB) based on WTP = €20,000.
Sensitivity analyses comparing 3 groups of the Active Plus intervention at the 12-month follow-up
|
|
|
|
|
| ||||
|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
| |||
| PA (MET hours/week) | 2760 (5301) | −2.2 | 2384 (4483) | 2.9 | 2789 (5992) | 0.2 | Print dominant | Print at any threshold |
| Print: 96% | ||||||||
| QALY-EQ-5D-3Lc | 2739 (5293) | 0.884 | 2365 (4427) | 0.879 | 2800 (6054) | 0.886 | 79196 (Print vs. C) | <€65000 Print, >€65000 C |
| Print: 65% | ||||||||
|
|
|
|
|
| ||||
|
|
|
|
|
|
| |||
| PA (MET hours/week) | 2760 (5301) | −2.2 | 2771 (5375) | 1.9 | 2400 (5203) | 1.2 | 503 (Environment vs. Basic) | <€550 Environment, >€550 Basic |
| Basic: 68% | ||||||||
| QALY-EQ-5D-3Lc | 2739 (5293) | 0.884 | 2754 (5381) | 0.879 | 2415 (5206) | 0.886 | Environment dominant | Environment at any threshold |
| Environment: 75% | ||||||||
PB = printed basic intervention, PE = printed environmental intervention, WB = Web-based basic intervention, WE = Web-based environmental intervention, C = control group.
aIn Euros; bcalculated according to the formula ICER = (Ci-Cc)/(Ui-Uc); cBased on the Dutch algorithm for the EuroQol (EQ-5D-3L) scores; dCost-effectiveness acceptability frontiers (CEAF); eProbability of highest net monetary benefit (NMB) based on WTP = €20,000.